Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Apple Investors Give Lukewarm Reaction to New Siri, AI Platform
39:20

Leadership Anatomy in Motion
08:39

Bloomberg Businessweek Weekend - June 5th, 2026
38:22